Verde G, Oppizzi G, Colussi G, Cremascoli G, Botalla L, Müller E E, Silvestrini F, Chiodini P G, Liuzzi A
Clin Endocrinol (Oxf). 1976 Jul;5(4):419-23. doi: 10.1111/j.1365-2265.1976.tb01971.x.
In ten normal subjects and in twenty acromegalic patients plasma levels of growth hormone were studied after administration of L-dopa and a dopamine infusion. In the ten normal subjects L-dopa, but not dopamine, increased plasma levels of GH. In the acromegalic patients both L-dopa and dopamine were followed by an inhibition of GH release. Since dopamine does not cross the blood-brain barrier, these results, although not excluding a site of action at median eminence level, support the thesis that the inhibitory effect of dopaminergic stimulation on GH release in acromegaly possibly involves receptors present on GH-secreting cells.
对10名正常受试者和20名肢端肥大症患者,在给予左旋多巴和多巴胺输注后,研究了生长激素的血浆水平。在10名正常受试者中,左旋多巴而非多巴胺可提高生长激素的血浆水平。在肢端肥大症患者中,左旋多巴和多巴胺之后均出现生长激素释放受抑制的情况。由于多巴胺不能穿过血脑屏障,这些结果虽不排除在正中隆起水平存在作用位点,但支持这样一种观点,即多巴胺能刺激对肢端肥大症患者生长激素释放的抑制作用可能涉及生长激素分泌细胞上存在的受体。